Insiders

26/11 Neurizon Therapeutics Limited Announces the Appointment of Justine Conway as Board Observer CI
22/25/22 Neurizon Therapeutics Appoints Don O'Connell as Chief Financial Officer; Shares Down 4% MT
22/25/22 Neurizon Therapeutics Appoints Dan O'Connell As CFO RE
22/25/22 Neurizon Therapeutics Limited Appoints Dan O'Connell as Chief Financial Officer CI
17/25/17 Neurizon Therapeutics Makes Three Executive Appointments; Shares Up 15% MT
31/24/31 PharmAust Reappoints CEO MT
17/24/17 PharmAust Appoints Nonexecutive Chair; Shares Up 3% MT
09/24/09 Pharmaust Appoints Interim Chair, Managing Director; Shares Fall 16% MT
23/24/23 Pharmaust CEO Resigns MT
07/24/07 PharmAust Appoints Non-Executive Director MT
28/23/28 PharmAust Limited Appoints Roger Aston as Non-Executive Chairman, Effective 1 September 2023 CI
28/23/28 PharmAust Limited Announces Executive Changes CI
13/23/13 Pharmaust Starts Search for Australia-Based CEO MT
27/22/27 PharmAust Limited Announces Resignation of Richard Mollard as Chief Scientific Officer CI
02/18/02 PharmAust Limited Announces Board Changes CI
21/18/21 PharmAust Limited Announces Executive Changes CI
18/17/18 PharmAust Appoints Barbara Kitchell to Veterinary Advisory Board CI
03/17/03 PharmAust Announces Appointments to Its Veterinary Clinical Advisory Board CI
08/17/08 PharmAust Limited Appoints Richard Mollard as Chief Scientific Officer CI
28/15/28 PharmAust Limited Announces Cessation of David Morris as Director CI
24/15/24 David Morris to Retire as Director of PharmAust Limited CI
30/13/30 PharmAust Limited Announces Cessation of Henry Gulev as Director CI
12/13/12 PharmAust Limited Announces the Resignation of Bryant Mclarty as a Director CI
05/13/05 PharmAust Limited Elects Roger Aston and David Morris as Directors CI
08/12/08 PharmAust Limited Announces Resignation of Greg Cunnold as Director CI
No results for this search